Enhancement of plasma fibrinolysis in vitro by jararhagin, the main haemorrhagic metalloproteinase in Bothrops jararaca venom.

[1]  C. Hay,et al.  Ineffectiveness of the inhibition of the main haemorrhagic metalloproteinase from Bothrops jararaca venom by its only plasma inhibitor, alpha 2-macroglobulin. , 1994, Biochimica et biophysica acta.

[2]  G. Ramadori,et al.  Contribution of sinusoidal endothelial liver cells to liver fibrosis: Expression of transforming growth factor‐β1 receptors and modulation of plasmin‐generating enzymes by transforming growth factor‐β1 , 1993 .

[3]  P. Gaussem,et al.  Sodium dodecyl sulfate-induced dissociation of complexes between human tissue plasminogen activator and its specific inhibitor. , 1993, The Journal of biological chemistry.

[4]  B. Konkle,et al.  Plasminogen activator inhibitor-1 mRNA is expressed in platelets and megakaryocytes and the megakaryoblastic cell line CHRF-288. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[5]  T. Urano,et al.  Dissociation of alpha 2-plasmin-inhibitor-plasmin complex and regeneration of plasmin activity by SDS treatment. , 1993, Thrombosis research.

[6]  E. Angles-cano,et al.  Neutralization of plasminogen activator inhibitor-1 (PAI-1) by activated protein C is species-dependent , 1993 .

[7]  A. Shapiro,et al.  Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation. , 1992, The New England journal of medicine.

[8]  M. Maruyama,et al.  Fibrinolytic enzymes in ascites during experimental acute pancreatitis in rats , 1992, International journal of pancreatology : official journal of the International Association of Pancreatology.

[9]  J. Meier,et al.  Purification and characterization of an antithrombin III inactivating enzyme from the venom of the African night adder (Causus rhombeatus). , 1992, Toxicon : official journal of the International Society on Toxinology.

[10]  M. Maruyama,et al.  Purification and characterization of two fibrinolytic enzymes from Bothrops jararaca (jararaca) venom. , 1992, Toxicon : official journal of the International Society on Toxinology.

[11]  M. Maruyama,et al.  Studies on Blood Coagulation and Fibrinolysis in Patients Bitten by Bothrops jararaca (jararaca) , 1990, Thrombosis and Haemostasis.

[12]  B. Bennett,et al.  Complexing of tissue plasminogen activator with PAI-1, alpha 2-macroglobulin, and C1-inhibitor: studies in patients with defibrination and a fibrinolytic state after electroshock or complicated labor. , 1990, Blood.

[13]  B. Bennett,et al.  Plasminogen activator in normal subjects after exercise and venous occlusion: t-PA circulates as complexes with C1-inhibitor and PAI-1. , 1987, Blood.

[14]  D. Belin,et al.  Amiloride selectively inhibits the urokinase‐type plasminogen activator , 1987, FEBS letters.

[15]  L. Nelles,et al.  Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin). , 1987, The Journal of biological chemistry.

[16]  C. Kluft,et al.  Plasminogen activator inhibitors. , 1987, Blood.

[17]  H. Lambers,et al.  Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family. , 1986, The EMBO journal.

[18]  E. Kruithof,et al.  Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. , 1984, Blood.

[19]  I. Clemmensen,et al.  Properties of Three Different Molecular Forms of the α2Plasmin Inhibitor , 1981 .

[20]  M. Griffith,et al.  Dissociation of antithrombin III--thrombin complex. Formation of active and inactive antithrombin III. , 1981, Biochemistry.

[21]  D. Collen.  On the Regulation and Control of Fibrinolysis , 1980, Thrombosis and Haemostasis.

[22]  M. Laskowski,et al.  Characterization of the inactive fragment resulting from limited proteolysis of human alpha1-proteinase inhibitor by Crotalus adamanteus proteinase II. , 1979, The Journal of biological chemistry.

[23]  Y. Sakata,et al.  Congenital Deficiency of α2-Plasmin Inhibitor Associated with Severe Hemorrhagic Tendency , 1979 .

[24]  A. Kamiguti,et al.  Thrombin-Like and Factor X-Activator Components of Bothrops Snake Venoms , 1979, Thrombosis and Haemostasis.

[25]  A. Granelli‐Piperno,et al.  A study of proteases and protease-inhibitor complexes in biological fluids , 1978, The Journal of experimental medicine.

[26]  N. Aoki,et al.  Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. , 1976, The Journal of biological chemistry.

[27]  S. Iwanaga,et al.  A simple, large scale method for preparation of plasminogen-free fibrinogen , 1972 .

[28]  D. Deutsch,et al.  Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.

[29]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[30]  T. Astrup,et al.  The fibrin plate method for estimating fibrinolytic activity. , 1952, Archives of biochemistry and biophysics.

[31]  R. Theakston,et al.  Systemic haemorrhage in rats induced by a haemorrhagic fraction from Bothrops jararaca venom. , 1991, Toxicon : official journal of the International Society on Toxinology.

[32]  R. Theakston,et al.  Development of simple standard assay procedures for the characterization of snake venom. , 1983, Bulletin of the World Health Organization.

[33]  A. P. Reichl,et al.  Some Physical and Biochemical Characteristics of HF2, One of the Hemorrhagic Factors in the Venom of Bothrops jararaca , 1976 .

[34]  K. Robbins,et al.  Plasminogen and plasmin. , 1976, Methods in enzymology.

[35]  A. Ohsaka,et al.  Animal, Plant, and Microbial Toxins , 1976, Springer New York.